Packaging concerns force Novartis, Sandoz to recall 12 drugs

Drugmakers Novartis and Sandoz recalled 12 medications July 6 because the packaging does not meet childproofing standards, CNN reports.

There are no quality or safety issues with the medications, so patients should continue to take them as prescribed, the companies said. The recall was only issued because the blister packaging used to contain the drugs doesn't meet U.S. federal requirements for child resistance, which poses a threat to child safety. There has been one report of a child ingesting haloperidol, an antipsychotic medication, from a blister pack.

All affected products were sold nationwide at clinics and pharmacies between September 2016 and June 2018.

The recalled products include various lots of the following:

  • Zofran ODT
  • Entresto
  • Azithromycin tablets
  • Donepezil ODT
  • Haloperidol
  • Imipramine HCl
  • Isosorbide Dinitrate
  • Naratriptan tablets
  • Ondansetron ODT
  • Ondansetron tablets
  • Perphenazine
  • Risperidone ODT

Find the full list of recalled products with their dosage and lot numbers here.

More articles on pharmacy:
Walgreens revamps pharmacist training after woman denied medicine: 7 things to know
Pfizer stock value dips after Trump's tweet
Pfizer hikes price of 100 drugs

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars